DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the YATHARTH HOSP & TRA C S L (YATHARTH) share price today?

YATHARTH HOSP & TRA C S L (YATHARTH) is trading at ₹844 on the NSE, down 1.78% on the day. Source: DocStoX.

What is the PE ratio of YATHARTH HOSP & TRA C S L?

YATHARTH HOSP & TRA C S L has a price-to-earnings (PE) ratio of 46.4 in the Healthcare sector.

What is the market capitalisation of YATHARTH HOSP & TRA C S L?

YATHARTH HOSP & TRA C S L has a market capitalisation of approximately ₹8,162 crore.

YATHARTH HOSP & TRA C S L

YATHARTH·NSE·Healthcare

₹844.00▼ -15.30 (-1.78%)

Healthcare · Hospitals

Revenue compounding 36% a year

Day₹840.00

₹858.95

52W₹538

₹89087%

Open

₹857.00

High

₹858.95

Low

₹840.00

Prev Close

₹859.30

Volume

1.10L

VWAP

₹846.29

Snapshot

Key fundamentals

Market Cap

₹8,162 Cr

P/E Ratio

46.37Expensive

P/B Ratio

4.66

EPS

₹18.20

Book Value

₹185.00

ROE

10.40%Average

ROCE

12.00%Decent

Dividend Yield

0.00%

Debt / Equity

0.15Low

Face Value

₹10.00

52W High

₹889.90

52W Low

₹538.25

Sector

Healthcare

Industry

Hospitals

Avoid

None moatHigh uncertainty

Fair value estimate

₹202

▼ 76.0%downside

Trading at ₹844 — 76% above our estimate

BearFair valueBull

₹172₹202₹275

/100

Business quality — Solid

Growth 100Profitability 47Efficiency 10Valuation 51

Plain English

Our view

Revenue compounding 36% a year
Low debt relative to equity
Fundamental red flags (Piotroski 3/9)

Strengths

Low debt relative to equity
Revenue compounding 36% over 3 years
Profit growing 37% a year
Promoters hold a controlling stake

Risks

Fundamental red flags (Piotroski 3/9)

How we got there

Fair value methods

Residual income

10% ROE fading to 12% over ~3 yrs, on ₹185 book

₹182

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹275

Analyst target

No analyst coverage

—

Blended fair value₹202

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Revenue compounding 36% over 3 years
Profit growing 37% a year
Promoters hold a controlling stake

Bear case

Fundamental red flags (Piotroski 3/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

46.4Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

10.4%Average

Above 15% is considered healthy for Indian equities

ROCE

12.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.15Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹8,162 Cr

P/B

4.66

EPS

₹18.20

Div Yield

—

What changed

Recent changes

Foreign investors-0.9% stake last quarter
Domestic institutions+1.0% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 46.4×

Growth

Strong

+36% rev CAGR

Profitability

Modest

10.4% ROE

Financial health

Rock solid

D/E 0.15

Momentum

N/A

No technicals

Today

Trading activity

Delivery %53.6%

Turnover₹930.64L Cr

Trades7,808

VWAP₹846.29

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+36.2%

+41.2%

10Y

—

Profit

+37.1%

+53.4%

10Y

—

EPS

+21.9%

+10.4%

10Y

—

Profile

Pros

Company is expected to give good quarter
Company has delivered good profit growth of 57.4% CAGR over last 5 years
Company's working capital requirements have reduced from 102 days to 80.1 days

Watch-outs

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Company has a low return on equity of 12.1% over last 3 years.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Foreign investors sold 0.93 pts; domestic institutions added 0.99 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

56%

Promoter

Promoters

55.8%0.00

Public

20.5%+0.16

FII / FPI

5.3%-0.93

DII

12.0%+0.99

Others

6.5%

Total shareholders

99,117+2,896 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter55.80%

FII5.25%

DII12.00%

Public20.47%

Others6.48%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospitals at Noida, Greater Noida, and Noida Extension, Uttar Pradesh.[1]